Pyxis Oncology, Inc. Quarterly Revenues in USD for Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Pyxis Oncology, Inc. quarterly Revenues history and growth rate for Q1 2024.
  • Pyxis Oncology, Inc. Revenues for the quarter ending March 31, 2024 was $16.1M.
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $16.1M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.